Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ AP2 gamma Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA584242
Description
Immunogen sequence: RSDLLLPHAH ALDAAGLAEN LGLHDMPHQM DEVQNVDDQH LLLHDQTVIR KGPISMTKNP LNLPCQKELV GAVMNPTE.
The protein encoded by this gene is a sequence-specific DNA-binding transcription factor involved in the activation of several developmental genes. The encoded protein can act as either a homodimer or heterodimer with other family members and is induced during retinoic acid-mediated differentiation. It plays a role in the development of the eyes, face, body wall, limbs, and neural tube.
Specifications
AP2 gamma | |
Polyclonal | |
Unconjugated | |
TFAP2C | |
AA409384; activating enhancer binding protein 2 gamma; activating enhancer-binding protein 2 gamma; activator protein 2 gamma; AP-2.2; AP2gamma; AP2-GAMMA; ERF1; estrogen receptor factor 1; hAP-2g; stimulated by retinoic acid gene 2; Stra2; Tcfap2c; TFAP2C; TFAP2G; Transcription factor AP-2 gamma; transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma); transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma); transcription factor AP-2, gamma; transcription factor ERF-1 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
7022 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry, Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q92754 | |
TFAP2C | |
Recombinant protein corresponding to Human TFAP2C. Recombinant protein control fragment (Product #RP-103852). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction